Capital Impact Advisors’s NantHealth, Inc NH Stock Holding History

Capital Impact Advisors’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,840	Closed	-$583K	–	155
2017 Q1	$583K	Buy	+7,840	New	+$873K	0.23%	155

Other funds holding NH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Impact Advisors's NH Position: Q2 2017 in Review

Capital Impact Advisors sold out of NantHealth, Inc (NH) in Q2 2017, closing a stake of 7,840 shares — an estimated $583K sold.

Capital Impact Advisors first reported a position in NH in Q1 2017 and held it in 1 quarter. The position peaked at $583K in Q1 2017. 46 funds tracked by Wall St. Rank hold NH as of Q2 2017.

Capital Impact Advisors reported no remaining NantHealth, Inc position as of Q2 2017 after selling out during the quarter.
Capital Impact Advisors sold 7,840 NantHealth, Inc shares in Q2 2017, an estimated $583K.
Capital Impact Advisors first reported a position in NantHealth, Inc in Q1 2017 and held it in 1 quarter.
Capital Impact Advisors's NantHealth, Inc position peaked at $583K in Q1 2017.
46 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2017.

Based on Capital Impact Advisors's 13F filing for Q2 2017, filed 18 Jul 2017.